Background illustration for clinical trials search

Paid Clinical Trials Sacramento

Discover 764 paid clinical trials in Sacramento, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Sacramento CA, Stanford CA, Orange CA, Seattle WA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Sacramento CA, San Francisco CA, Los Angeles CA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase 1, Recruiting

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for
Non-small Cell Lung Cancer
Location: Sacramento CA, Reno NV, Santa Monica CA, Tucson AZ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06561386

Phase 3, Recruiting

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

for
Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06268665

Phase 2, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Sacramento CA, Stanford CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

XTX301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Sacramento CA, Saint Louis Park MN, St Louis MO,
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT05684965

Phase 1, Phase 2, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Sacramento CA, Palo Alto CA, Orange CA, Seattle WA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

for
Advanced Prostate Adenocarcinoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: Male

Age: 18+

Code: NCT06173362

Phase 2, Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

for
Neuroblastoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma,
Location: Sacramento CA, Oakland CA, San Diego CA,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 30

Code: NCT06541262

Phase 1, Phase 2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Sacramento CA, Oakland CA, San Francisco CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education

for
Cancer Awareness and Prevention Education
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18 - 70+

Code: NCT05761782

Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Sacramento CA, Stanford CA, Los Angeles CA, Irvine CA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase 1, Phase 2, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Sacramento CA, Berkeley CA, San Francisco CA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

for
Metastatic Nonsmall Cell Lung Cancer
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06228482

Phase 1, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Sacramento CA, Oakland CA, Stanford CA, San Diego CA,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase 2, Recruiting

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Sacramento CA, Berkeley CA, Palo Alto CA, Post Falls ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07393555

Phase 2, Recruiting

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: Sacramento CA, Reno NV, Los Angeles CA, Orange CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase 3, Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: Sacramento CA, San Francisco CA, Los Angeles CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase 3, Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Sacramento CA, Palo Alto CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06661915

Phase 2, Recruiting

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

for
Hemophagocytic Lymphohistiocytoses
Location: Sacramento CA, San Francisco CA, Irvine CA,
Sponsor: Jerry Lee, MD, MSc, MPhil

Sex: All

Age: 18+

Code: NCT06160791

Phase 2, Recruiting